File #: 981662    Version: 1 Name: Accessible Hepatitis C Treatment
Type: Resolution Status: Passed
Introduced: 10/5/1998 In control: Board of Supervisors
On agenda: 10/13/1998 Final action: 10/23/1998
Enactment date: Enactment #: 845-98
Title: Resolution urging Schering-Plough Pharmaceuticals to unbundle the anti-viral agent ribavirin, implement a 75 percent price cut, implement a comprehensive patient assistance program, and cease all aggressive sales tactics.
Sponsors: Leland Y. Yee, Mark Leno, Leslie Katz
Attachments: 1. Leg_Final
Date Ver.Action ByActionResultAction DetailsMeeting DetailsVideo
10/23/19981 Mayor APPROVED  Action details Meeting details Not available
10/13/19981 Board of Supervisors ADOPTEDPass Action details Meeting details Not available
10/5/19981 President REFERRED FOR ADOPTION WITHOUT COMMITTEE REFERENCE AGENDA AT THE NEXT BOARD MEETING  Action details Meeting details Not available
Legislation Details
 *NOTE: These reports are produced in HTML format and are accessible to screen readers.